Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:12 pm Purchase | 13G | Sana Biotechnology, Inc. SANA | ARCH Venture Fund IX L.P. | 46,028,125 20.600% | 1,883,181 (+4.27%) | View |
| 2024-11-14 06:00 am Unchanged | 13G | Sana Biotechnology, Inc. SANA | CANADA PENSION PLAN INVESTMENT BOARD | 10,175,000 4.600% | 0 (Unchanged) | View |
| 2024-11-12 4:52 pm Unchanged | 13G | Sana Biotechnology, Inc. SANA | The Vanguard Group - 23-1945930 | 13,183,552 5.920% | 0 (Unchanged) | View |
| 2024-11-12 10:34 am Purchase | 13G | Sana Biotechnology, Inc. SANA | FMR LLC | 31,609,175 14.208% | 9,441,625 (+42.59%) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | Sana Biotechnology, Inc. SANA | BlackRock Inc. BLK | 11,817,380 5.300% | 0 (Unchanged) | View |
| 2024-11-04 2:10 pm Purchase | 13G | Sana Biotechnology, Inc. SANA | The Vanguard Group - 23-1945930 | 13,183,552 5.920% | 13,183,552 (New Position) | View |
| 2024-10-22 6:06 pm Purchase | 13G | Sana Biotechnology, Inc. SANA | BlackRock Inc. BLK | 11,817,380 5.300% | 11,817,380 (New Position) | View |
| 2024-04-03 09:52 am Purchase | 13G | Sana Biotechnology, Inc. SANA | FMR LLC | 22,167,550 10.055% | 6,416,259 (+40.73%) | View |
| 2024-03-07 07:01 am Purchase | 13G | Sana Biotechnology, Inc. SANA | BAILLIE GIFFORD & CO | 10,360,620 4.700% | 210,603 (+2.07%) | View |
| 2024-02-14 4:19 pm Sale | 13G | Sana Biotechnology, Inc. SANA | Flagship Ventures Fund V L.P. | 25,583,551 13.000% | -8,655,467 (-25.28%) | View |
| 2024-02-09 5:35 pm Purchase | 13G | Sana Biotechnology, Inc. SANA | ARCH Venture Fund IX L.P. | 44,144,944 22.400% | 65,536 (+0.15%) | View |
| 2024-02-09 09:49 am Purchase | 13G | Sana Biotechnology, Inc. SANA | FMR LLC | 15,751,291 7.990% | 6,046,193 (+62.30%) | View |
| 2024-01-26 06:49 am Sale | 13G | Sana Biotechnology, Inc. SANA | BAILLIE GIFFORD & CO | 10,150,017 5.150% | -614,710 (-5.71%) | View |
| 2023-04-26 08:13 am Purchase | 13G | Sana Biotechnology, Inc. SANA | FMR LLC | 9,705,098 5.071% | 535,688 (+5.84%) | View |
| 2023-02-13 4:07 pm Purchase | 13G | Sana Biotechnology, Inc. SANA | ARCH Venture Fund IX L.P. | 44,079,408 23.100% | 817 (+0.00%) | View |
| 2023-02-09 08:14 am Sale | 13G | Sana Biotechnology, Inc. SANA | FMR LLC | 9,169,410 4.807% | -323,585 (-3.41%) | View |
| 2023-01-20 07:41 am Sale | 13G | Sana Biotechnology, Inc. SANA | BAILLIE GIFFORD & CO | 10,764,727 5.640% | -497,303 (-4.42%) | View |
| 2022-05-19 08:27 am Purchase | 13G | Sana Biotechnology, Inc. SANA | FMR LLC | 9,492,995 5.005% | 865,144 (+10.03%) | View |
| 2022-02-14 4:48 pm Purchase | 13G | Sana Biotechnology, Inc. SANA | CANADA PENSION PLAN INVESTMENT BOARD | 10,175,000 5.400% | 10,175,000 (New Position) | View |
| 2022-02-14 3:02 pm Purchase | 13G | Sana Biotechnology, Inc. SANA | Flagship Ventures Fund V L.P. | 34,239,018 18.100% | 34,239,018 (New Position) | View |